4
Changes in Ownership
CORCEPT THERAPEUTICS INC Filed Acc 0000899243-21-039272
Chief Commercial Officer sold 25,000 shares at an average $20.00 ($500,115)
- Chief Commercial Officer acquired 25,000 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Maduck Sean Chief Commercial Officer | 2021-10-01 | Option exercise | +24,363 | $3.29 | $80,154 | 64,387 | D |
| Maduck Sean Chief Commercial Officer | 2021-10-01 | Sale | −24,363 | $20.00 | $487,375 | 40,024 | D |
| Maduck Sean Chief Commercial Officer | 2021-10-05 | Option exercise | +637 | $3.29 | $2,096 | 40,661 | D |
| Maduck Sean Chief Commercial Officer | 2021-10-05 | Sale | −637 | $20.00 | $12,740 | 40,024 | D |
| Derivatives | |||||||
| Maduck Sean Chief Commercial Officer | 2021-10-01 | Option exercise · Stock Option (Right to Buy) | −24,363 | 123,239 | D | ||
| Maduck Sean Chief Commercial Officer | 2021-10-05 | Option exercise · Stock Option (Right to Buy) | −637 | 122,602 | D | ||
| Open-market sales · 25,000 sh · avg $20.00 · $500,115 | |||||||
Loading xslF345X03/doc4.xml…